2Suppliers
9Customers
1Debt Items
20Related Chains

Source-Backed Evidence Depth

PureTech Health plc (PRTC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

12Total relationships
1Distinct source URLs
4High confidence
0.762Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

PureTech Health plc Suppliers

TickerNameConfidenceEvidence
VEDANTA VEDANTA 80% we entered into a Secured Convertible Promissory Note Purchase Agreement with Vedanta
CGEN Compugen Ltd. 72% Reciprocal relationship from CGEN graph: d Compugen. Dr. Livnat Savitzky holds a B.Sc. in Biology from The Hebrew University of Jerusalem, and an M.S.c and Ph.D. with distinction in Human Genetics fr…

PureTech Health plc Customers

TickerNameConfidenceEvidence
RPRX Royalty Pharma plc 90% Upon closing, we received an upfront payment of $100.0 million from Royalty Pharma
RPRX Royalty Pharma plc 90% Reciprocal relationship from RPRX graph: Reciprocal relationship from PRTC graph: Reciprocal relationship from RPRX graph: Reciprocal relationship from PRTC graph: Upon closing, we received an upfron…
RNTX Rein Therapeutics Inc. 72% Reciprocal relationship from RNTX graph: Reciprocal relationship from PRTC graph: Reciprocal relationship from RNTX graph: Reciprocal relationship from PRTC graph: Reciprocal relationship from RNTX g…
SPTX SPTX 72% Reciprocal relationship from SPTX graph: Reciprocal relationship from PRTC graph: . During the year ended December 31, 2024 , Seaport Therapeutics, Inc. was deconsolidated and as such, $ 225 in net i…
SPTX SPTX 72% . During the year ended December 31, 2024 , Seaport Therapeutics, Inc. was deconsolidated and as such, $ 225 in net intangible assets were derecognized. The Group tested all intangible assets for imp…
VOR Vor Biopharma Inc. 72% Reciprocal relationship from VOR graph: Reciprocal relationship from PRTC graph: er the Group participates in the policy making processes of the investee, whether there is any interchange of manageri…
VOR Vor Biopharma Inc. 72% er the Group participates in the policy making processes of the investee, whether there is any interchange of managerial personnel, whether there is any essential technical information provided to th…
SEAPORT-THERAPEUTICS SEAPORT-THERAPEUTICS 70% we entered into an Asset Transfer Agreement, by and among Seaport, PureTech Health LLC and PureTech LYT, Inc.
JEF Jefferies Financial Group Inc. 62% Reciprocal relationship from JEF graph: Reciprocal relationship from PRTC graph: Reciprocal relationship from JEF graph: Reciprocal relationship from PRTC graph: Reciprocal relationship from JEF grap…

PureTech Health plc Debt Obligations

InstrumentDescriptionConfidenceEvidence
PRTC-DEBT Debt stack $203.3M 90% Market cache reports total debt of $203.3M.

PureTech Health plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for PureTech Health plc.

PureTech Health plc Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for PureTech Health plc.

PureTech Health plc Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
RPRX Royalty Pharma plc 100.00 1 ['customer']
SWKH SWK Holdings Corp 100.00 2
RVMD Revolution Medicines, Inc. 100.00 2
RNTX Rein Therapeutics Inc. 100.00 1 ['customer']
NUVL Nuvalent, Inc. 100.00 2
SPTX Seaport Therapeutics, Inc. 100.00 1 ['customer']
GRFS Grifols, S.A. 100.00 2
MYGN Myriad Genetics, Inc. 100.00 2
SNYNF Sanofi 100.00 2
RNAC Cartesian Therapeutics, Inc. 100.00 2
JEF Jefferies Financial Group Inc. 100.00 1 ['customer']
JNJ Johnson & Johnson 100.00 2
NVSEF Novartis AG 100.00 2
VOR Vor Biopharma Inc. 100.00 1 ['customer']
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
CGEN Compugen Ltd. 100.00 1 ['supplier']
JBIO Jade Biosciences, Inc. 100.00 2
GDHG Golden Heaven Group Holdings Ltd. 50.00 2
FMFC Kandal M Venture Limited 50.00 2
CHT Chunghwa Telecom Co., Ltd. 50.00 2
🔐
PRTC
Unlock PRTC Supply Chain Data
Verified relationships include:
VEDANTAVEDANTASupplier80%
CGENCompugen Ltd.Supplier72%
RPRXRoyalty Pharma plcCustomer90%
RPRXRoyalty Pharma plcCustomer90%
+8 more relationships locked
Subscribe, View plans →